The statin diabetes conundrum: short-term gain, long-term risk or inconvenient truth?
- PMID: 26180130
- DOI: 10.1136/ebmed-2015-110236
The statin diabetes conundrum: short-term gain, long-term risk or inconvenient truth?
Erratum in
-
Correction.Evid Based Med. 2016 Feb;21(1):13. doi: 10.1136/ebmed-2015-110236corr1. Evid Based Med. 2016. PMID: 26801907 No abstract available.
Keywords: PREVENTIVE MEDICINE.
Similar articles
-
[Guideline for management of lipid metabolism].Nihon Rinsho. 2002 Sep;60 Suppl 9:675-8. Nihon Rinsho. 2002. PMID: 12387068 Review. Japanese. No abstract available.
-
Letter: viewing JUPITOR with a clear perspective.Evid Based Med. 2009 Jun;14(3):70. doi: 10.1136/ebm.14.3.70. Evid Based Med. 2009. PMID: 19483020 No abstract available.
-
[Ongoing clinical trials by vascular statin, cerivastatin].Nihon Rinsho. 2001 Mar;59 Suppl 3:477-82. Nihon Rinsho. 2001. PMID: 11347117 Review. Japanese. No abstract available.
-
Commentary on 'Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis' by Preiss et al.Diab Vasc Dis Res. 2012 Jan;9(1):78. doi: 10.1177/1479164111430337. Diab Vasc Dis Res. 2012. PMID: 22158545 No abstract available.
-
[Statin therapy and the development of diabetes mellitus].Ugeskr Laeger. 2014 Feb 3;176(3):218. Ugeskr Laeger. 2014. PMID: 24629746 Danish. No abstract available.
Cited by
-
Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.Am J Cardiovasc Drugs. 2017 Apr;17(2):135-142. doi: 10.1007/s40256-016-0197-9. Am J Cardiovasc Drugs. 2017. PMID: 27837448 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical